Department of Health Psychology, University of Missouri, Columbia, MO 65203, USA.
Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Int J Environ Res Public Health. 2023 Jan 29;20(3):2373. doi: 10.3390/ijerph20032373.
Pediatric obesity is common and a significant burden. Supplementing pediatric obesity treatment with technology is needed. This manuscript examines the usability and satisfaction, as well as explores initial effectiveness, of a remote patient monitoring system (RPMS) designed for youth presenting for pediatric weight management treatment.
47 youth, 10 to 17 years old, with obesity and a caregiver participated. For three months, families received treatment via the RPMS. Usability and satisfaction outcomes were examined. Exploratory analyses were conducted to examine initial effectiveness from baseline and post-treatment (month 3) assessments.
More than 80% of patients used the RPMS, and overall, patients completed 27 out of 90 daily sessions (30%). Youth and caregivers reported high satisfaction. Non-parametric tests revealed no significant improvements for youth or caregiver weight status after the RPMS treatment. Significant improvements in other outcomes examined were limited.
Families were satisfied with the RPMS, but use of the system was limited. Initial effectiveness was not able to be determined due to the amount of missing data, which was impacted by the COVID-19 pandemic. Modifications of the RPMS and future evaluation of usability and effectiveness are warranted to determine utility in supplementing pediatric obesity clinical treatment.
儿科肥胖症较为常见,是一个重大负担。需要利用技术为儿科肥胖症治疗提供补充。本文旨在研究一款专为儿科体重管理治疗就诊青少年设计的远程患者监测系统(RPMS)的可用性和满意度,同时探索其初步疗效。
共有 47 名年龄在 10 至 17 岁的肥胖青少年及其一名照顾者参与了本次研究。在三个月的时间里,这些家庭通过 RPMS 接受治疗。对其可用性和满意度进行了评估。通过基线和治疗后(第 3 个月)评估进行了初步疗效的探索性分析。
超过 80%的患者使用了 RPMS,总体而言,患者完成了 90 次日常治疗中的 27 次(30%)。青少年和照顾者报告了高度的满意度。非参数检验显示,在接受 RPMS 治疗后,青少年或照顾者的体重状况没有显著改善。其他检查的结果也仅有一些显著改善。
尽管由于 COVID-19 大流行,数据缺失量较大,影响了初步疗效的评估,但家庭对 RPMS 的满意度较高。由于系统使用受限,需要对 RPMS 进行改进,并进一步评估其可用性和疗效,以确定其在补充儿科肥胖症临床治疗方面的应用价值。